THE IMPACT OF MEDICARE PART D ON HEALTH CARE UTILIZATION AND HEALTH OUTCOMES FOR MEDICARE BENEFICIARIES WITHOUT PREVIOUS DRUG COVERAGE

Author(s)

Xiao Qing LIU/Mr, MS, Student, Surrey M. Walton, PhD, Associate Professor, Stephanie Y. Crawford, PhD, Associate professor, A. Simon Pickard, PhD, Associate ProfessorUniversity of Illinois at Chicago, Chicago, IL, USA

OBJECTIVES To examine, using nationally representative data, the impact of Medicare Part D on medication utilization, out-of-pocket-costs, non-drug medical service utilization, and health outcomes among civilian non-institutionalized Medicare beneficiaries without prescription drug coverage prior to the implementation of Medicare Part D. METHODS The primary data were from the Medical Expenditure Panel Survey (MEPS) panel 10 data and the corresponding 2005 and 2006 pharmacy component data. This study included Medicare beneficiaries between 65 and 79 years old that had only Medicare Fee for Service (FFS) in 2005. Patients between 55 and 63 years old with no drug coverage in 2005 served as control subjects. Difference-in-differences was used to identify the effects of Medicare Part D on health care utilization, expenditures, non-drug medical service utilization, and health outcomes among Medicare beneficiaries. RESULTS The mean amount paid by the near elderly without insurance in 2005 declined 7.8%, while the mean amount paid by Medicare beneficiaries with Medicare FFS only in 2005 decreased 40.6%. The number of prescription refills of the near elderly increased 10.35%, while there was only 4.3% increase among the Medicare beneficiaries. ER visits among the Medicare FFS group declined 2.6%, while the number of ER visits among the near elderly increased 0.94%. There was only small growth rate difference in other outcomes variable. CONCLUSIONS Evidence from the MEPS data set suggests that Medicare Part D reduced out of pocket costs, drug utilization, and ER visits among patients without prior coverage. While cost reduction was expected, the reduction in utilization of drugs was not. Future research should further examine these trends.

Conference/Value in Health Info

2009-05, ISPOR 2009, Orlando, FL, USA

Value in Health, Vol. 12, No. 3 (May 2009)

Code

PIH45

Topic

Health Policy & Regulatory

Topic Subcategory

Pricing Policy & Schemes

Disease

Geriatrics, Pediatrics

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×